Projects funded by the NCN
Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation in an Animal Model of Treatment-Resistant Depression
2024/53/B/NZ7/00671
Keywords:
Psylocybin Dimerization 5-HT1A receptor 5-HT2B receptor Glycogen synthase kinase 3β (GSK-3β) Treatment-Resistant Depression
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj.
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 2 374 820 PLN
Project start date (Y-m-d): 2025-02-10
Project end date (Y-m-d): 2029-02-09
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.